ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges

Chow L.Q.M.Barlesi F.Bertino E.M.Van Den Bent M.J.Wakelee H.A.Wen P.Y.Chiu C.-H.Orlov S.Chiari R.Majem M.McKeage M.CHONG-JEN YUGarrido P.Hurtado F.K.Arratia P.C.Song Y.Branle F.Shi M.Kim D.-W.2022-06-272022-06-2720221078-0432https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131604877&doi=10.1158%2f1078-0432.CCR-21-1838&partnerID=40&md5=a4b83c5774f9242a83c2f2eff545f3b2https://scholars.lib.ntu.edu.tw/handle/123456789/613968[SDGs]SDG3ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeningesjournal article10.1158/1078-0432.CCR-21-1838350914432-s2.0-85131604877